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The human connectome at the level of fiber tracts between brain regions has been shown
to differ in patients with brain disorders compared to healthy control groups. Nonetheless,
there is a potentially large number of different network organizations for individual patients
that could lead to cognitive deficits prohibiting correct diagnosis. Therefore changes that
can distinguish groups might not be sufficient to diagnose the disease that an individual
patient suffers from and to indicate the best treatment option for that patient. We describe
the challenges introduced by the large variability of connectomes within healthy subjects
and patients and outline three common strategies to use connectomes as biomarkers
of brain diseases. Finally, we propose a fourth option in using models of simulated
brain activity (the dynamic connectome) based on structural connectivity rather than
the structure (connectome) itself as a biomarker of disease. Dynamic connectomes, in
addition to currently used structural, functional, or effective connectivity, could be an
important future biomarker for clinical applications.
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The study of how different components of the brain, may they
be neurons or brain regions, are connected has become an
emerging field within the neurosciences (Sporns et al., 2004;
Bullmore and Sporns, 2009; Kaiser, 2011). The analysis of physi-
cal connections within neural systems gained momentum around
20 years ago with the availability of information on the nematode
Caenorhabditis elegans’ nervous system (White et al., 1986;
Achacoso and Yamamoto, 1992) and the rhesus monkey’s visual
system of cortico-cortical connections (Felleman and van Essen,
1991; Young, 1992). Now called connectomics, the field aims to
discover the structure of brain networks, representing physical
connections such as axons or fiber tracts. As a next milestone,
the first data sets of the Human Connectome Project are being
released. What will the next 20 years bring? Like for genomics,
the hopes are that features of the connectome of a patient can
be a biomarker for diseases and an indicator for therapeutic
interventions. Identifying biomarkers for diseases based on
large-scale genome studies has been challenging. Is the link
between connectivity and brain disease also over-weighted? What
could a structural connectome in principle tell us about the brain
organization in health and disease?
In analogy to genetics, we may distinguish a genotype and
a phenotype of brain organization. The genotype is given
by the structural connectivity either observed at the level of
individual synapses (microconnectome) or at the level of fiber
tracts between brain regions (macroconnectome) (DeFelipe,
2010) and we will refer to this as connectome. As for every novel
field, the underlying techniques are still under development
(Jbabdi and Johansen-Berg, 2011). Diffusion tensor and diffusion
spectrum imaging can give us information on potential structural
connections of the macroconnectome. The phenotype represents
activity, as seen in functional Magnetic Resonance Imaging
(fMRI) or EEG, or behavior, as for cognitive clinical scores. We
refer to these patterns as consequences on dynamics or behavior
due to changed brain connectivity.
The problem of diagnosing a disease, as in genetics, is due
to the fact that several mutations of the genotype might result
in the same phenotype (disease). Observing brain connectivity,
there might be several combinations of changes in fiber tracts
leading to hallucinations or seizures, for example. Also, the same
connectome organization might lead to different dynamics for
changes that affect the internal anatomy and activity of net-
work nodes but not the nodes’ topology (Figure 1). The idea
that many pathways can lead to similar behavior is linked to
the concept of degeneracy (Tononi et al., 1999; Price and Friston,
2002), “the ability of elements that are structurally different to
perform the same function or yield the same output.” If the
output (phenotype) is cognitive deficits in patients, the number
of connectome (genotype) patterns that lead to such behav-
ior can be seen as the degeneracy of a brain disease. Also, a
higher degeneracy, meaning that more connectome patterns are
linked to a disease, might result in a higher incidence in a
population. A related observation has been made in the field
of genetics when linking genetic changes to diseases: multiple
genotypes might lead to the same phenotype (heterogeneity)
(Addington and Rapoport, 2012). Therefore, detecting one con-
nectivity pattern linked to a disease might only relate to a fraction
of all patients. Moreover, many connectome changes will be
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FIGURE 1 | Mapping between underlying developmental causes of
connectome changes, ranging from genetic factors to spatiotemporal
epigenetic factors, to resulting brain connectivity (“connectome”),
observable network behavior (“consequence”), and final disease
classification. Similar patterns within each of the four categories are
shown in red. Note that both genetic patterns and network features alone
may be insufficient to inform the clinical diagnosis of a disease: first, the
same genetic mutation A might lead to a different connectivity due to
different epigenetic factors. Second, different genetic mutations A and B
could lead to the same connectivity due to additional factors. Third, the
same connectivity might lead to different behavior and disease
classification due to changes that solely affect the anatomical organization
within individual nodes.
neutral in that they do not lead to a brain disorder; thus variability
in the healthy population is expected to be large as well. As for
genetics, connectomics is currently moving to large-scale studies,
e.g., the 1,200-subject Human Connectome Project or the 1,000-
subject Functional Connectomes study, to address this underlying
variability.
Another problem besides large connectome variability
(“noise”) is that cognitive deficits might arise from small
changes (“signal”). Development can be seen as a system of
nonlinear dynamics (Turing, 1952). It has become clear that
genetic encoding (Kendler et al., 2011) and self-organization
shape the formation of neural systems in health and disease.
For self-organization, the interaction with the environment
(external factors) or physical constraints (internal factors) can
influence the establishment and survival of axonal connections.
Consequently, small changes during development might lead to
a different connectome and as a result to a different resulting
consequence for cognition and behavior of human subjects. As
the dynamics in the brain are also non-linear, a small change in
structural connectivity might be sufficient to lead to changes in
cognition and behavior. Relatively small changes in connectivity
might be sufficient to lead to a brain disorder. Therefore, some
connectivity patterns seen in patients might be quite close to the
organization of healthy subjects.
Let us look at some cases of how brain diseases could be linked
to brain connectivity. Also, let us only use two cases of how a net-
work structure (edge or node) in a patient could differ from that
of a control group: a significant increase or a significant decrease
of a network measure. We will only look at a single measure here,
say number of streamlines for edges and total strength of its con-
nections for nodes, but our general observations also hold for a
combination of network measures (Costa et al., 2007; Kaiser et al.,
2009; van den Heuvel et al., 2012).
First, a disease might affect a single brain region which could
have an effect on brain dynamics by changing its own activity
pattern, the pattern of directly connected neighbors of the region,
and, indirectly, the activity in the rest of the brain mediated by
intermediate brain regions. As a simplification, let us assume
that only structural connections from that brain region will be
altered. As each brain region (for a parcellation in humans of 110
cortical and subcortical regions including both hemispheres) is
connected to around 10 other brain regions, there are 210 = 1,024
possible changes assuming that each connection could either be
significantly increased or decreased in a patient. Thus even at the
local scale, only affecting a single brain region, many variations of
a disease are possible.
Second, a disease could affect a set of network nodes. For
example, regions of the neocortex mature at different times dur-
ing development: medial regions before lateral regions and pos-
terior before anterior regions. A change in the maturation of
the frontal lobe could affect multiple regions at the same time
and might affect a whole network module (Nisbach and Kaiser,
2007). Say that 10 regions show a different internal structure
that also manifests itself in altered fiber tracts between them and
other brain regions. Therefore, assuming 10 fiber tracts per brain
region, or 102 = 100 fiber tracts for all 10 affected regions, show
changes leads to 2100 = 1.3∗1030 variants. Let us look at a simpler
model where an increase (or a reduction) in at least 10 of those
100 fiber tracts is sufficient to lead to the behavioral features of a
disease. There are
(
100
10
)
= 1.7∗1013 ways to choose 10 out of 100
connections. Given that 10 is the lower bound for disease onset,
choosing 11, 12, 13, etc. connections leads to evenmore variations
at this regional level.
Third, a disorder could lead to changes of a set of edges at the
global level as a result of widely distributed changes. If there are
500 bidirectional connections (fiber tracts) between our 110 brain
regions, there are 2500 = 3.3∗10150 possible changes compared to
a benchmark brain based on a population of healthy subjects.
We know that there is huge variability not only in the surface
shape of human brains but also in its related connectivity pat-
tern (Van Essen, 1997; Hilgetag and Barbas, 2006). Clearly, only
a small fraction of connectome patterns is linked to a brain
disorder. Even if we assume that there are thousands of subtypes
of brain disorders, e.g., different kinds of epilepsy, and that many
diseases change synaptic efficacy without changing structural con-
nectivity, there might still be billions of connectome changes that
could lead to the clinical patterns observed in patients with one
type of a disease. Clearly, no two patients are the same (neither
are no two control subjects).
If there is a multitude of ways how connectome changes could
lead to a disease, how can we use brain connectivity information
to inform the diagnosis and treatment of clinical patients? First,
some links between connectome and consequential brain dynam-
ics might manifest themselves through changes of global net-
work features despite the variability in the changes of individual
connections. Examples are global topological changes, observed
through diffusion tensor imaging, in remitted geriatric depres-
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sion and amnestic mild cognitive impairment (Bai et al., 2012).
However, the same global changes, say a deviation from the brain’s
small-world organization towards randomor regular connectivity
(Reijneveld et al., 2007), could be observed across diseases and
therefore limit their use as a classifier for brain diseases.
Second, some changes might be so widespread that they
affect the majority or all of the brain regions leaving fewer
degrees of freedom for variability in connectomes. The overall
pattern of altered structural connectivity in schizophrenia
patients (Skudlarski et al., 2010), along with resulting functional
connectivity changes (Fornito et al., 2012), would be one example
for this case.
Third, changes that are linked to a brain disease might only
affect specific circuits in the network. In that way, while the
strength of most connections also varies in healthy controls, more
consistent changes to specific fiber tracts would be expected for
patients. As a consequence, changes in selected circuits would be
common for a group of patients but a consistent change for all
fiber tracts of a circuit would not occur in control subjects. While
this is a potentially powerful approach it does need a priori knowl-
edge about the affected circuit. Such circuits might be identified
by large-cohort studies in patients or through “knock-out” stud-
ies, e.g., using transcranial magnetic stimulation (Hilgetag et al.,
2001), in healthy subjects.
Finally, I would propose a novel approach to deal with the
variability in brain disorders, which is the use of computer
simulations of brain activity, based on the connectivity in
individual patients. Such simulations are already emerging as
a way to understand the structural correlates of dynamical
changes and disease progression (Deco et al., 2011; Cabral et al.,
2012; Raj et al., 2012). As shown above, multiple structural
connectivity changes might lead to the same changes in brain
dynamics, patient behavior, or clinical test scores. Simulating the
activity in the brain of individual patients can inform us about
the expected behavioral features and thus about the presence or
absence of one sub-type of brain disorder. These models can go
beyond the observation of patterns in the recordings of brain
activity as simulated dynamics could include more complex
models. For example, a model based on structural connectivity
might include simulated activity of individual neurons or
local circuits, which cannot be observed by non-invasive
neuroimaging.
Using simulations in a clinical setting has several benefits.
First, simulated behavioral features can be mapped to brain
activity in patients that is available through fMRI, Positron Emis-
sion Tomography (PET),Magnetoencephalography (MEG), EEG,
Electrocorticography (ECoG), or recordings in resected tissue
(Roopun et al., 2010), depending on the disease. Second, the
simulated behavior can be compared with the experimentally
obtained behavior to validate and constrain a model: simulated
activity can be compared with the clinical recordings of a patient.
Third, observing dynamics in networks opens up the possibility to
use the tools of nonlinear dynamics and time series analysis to find
patterns that could be biomarkers for a given disease. Importantly,
changes in brain dynamics might be visible even in cases where the
structural connectivity is not significantly different from that of a
healthy control group. Such simulations are becoming available
both at the local (Blue Brain Project, Markram, 2006) and global
level (Virtual Brain Project, Jirsa et al., 2010) and will be support
through the Human Brain Project and other initiatives.
In conclusion, there is a large number of underlying structural
connectome changes that might lead to the same functional and
behavioral changes in healthy subjects and patients. This variety
makes the detection of a brain disorder—not just the classification
of the type of disorder (Hyman, 2010)—difficult. We propose the
use of computer models to use the simulated dynamics (dynamic
connectome) based on structural connectivity, rather than the
directly measured structural connectivity alone, as a biomarker.
In the same way that biology has moved from genes to gene
expression data, the use of dynamic connectomes, observing or
simulating activity in neural circuits, opens up future potential
for clinical applications.
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